The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $123.18

Today's change-4.62 -3.62%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $123.18

Today's change-4.62 -3.62%
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc down (U.S.)$4.62

Thermo Fisher Scientific Inc closed sharply lower Friday, dropping (U.S.)$4.62 or 3.62% to (U.S.)$123.18. Over the last five days, shares have lost 6.72% and are down 13.16% for the last year to date. This security has outperformed the S&P 500 by 5.81% during the last year.

Key company metrics

  • Open(U.S.) $127.00
  • Previous close(U.S.) $127.80
  • High(U.S.) $127.25
  • Low(U.S.) $121.30
  • Bid / Ask-- / --
  • YTD % change-13.16%
  • Volume4,172,149
  • Average volume (10-day)2,651,600
  • Average volume (1-month)2,339,006
  • Average volume (3-month)2,014,740
  • 52-week range(U.S.) $117.10 to (U.S.) $143.65
  • Beta1.02
  • Trailing P/E25.00×
  • P/E 1 year forward15.50×
  • Forward PEG1.62×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.49%
  • Trailing EPS(U.S.) $4.93
Updated February 5 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+11.67%

Based on its net profit margin of 11.67%, Thermo Fisher Scientific Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 26, 201509/26/2015Jun 27, 201506/27/2015Mar 28, 201503/28/2015
Revenue4,6534,1234,2713,919
Total other revenue--------
Total revenue4,6534,1234,2713,919
Gross profit2,2131,8831,9421,823
Total cost of revenue2,4402,2402,3292,096
Total operating expense3,9623,5603,6753,432
Selling / general / administrative9691,1091,1481,130
Research & development180172175166
Depreciation / amortization326------
Interest expense (income), net operating--------
Unusual expense (income)47402440
Other operating expenses, total--------
Operating income690563596487
Interest income (expense), net non-operating-103-101-103-108
Gain (loss) on sale of assets--------
Other--------
Income before tax583468504382
Income after tax606477512385
Income tax, total-24-9-8-3
Net income603476512385
Total adjustments to net income--------
Net income before extra. items606477512385
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items606477512385
Inc. avail. to common incl. extra. items603476512385
Diluted net income603476512385
Dilution adjustment--------
Diluted weighted average shares402402402401
Diluted EPS excluding extraordinary itemsvalue per share1.511.191.270.96
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.581.251.311.02